| Address:
|
11755 WILSHIRE BLVD., 20TH FLOOR
|
| City: |
LOS ANGELES |
|
State: |
CA |
|
Zip Code: |
90025 |
| Telephone: |
310-883-1300 |
|
Description of Business
|
Primary SIC Code:
2834 |
| (As filed with the SEC)
|
|
|
Unless the context otherwise requires, references to "New Abraxis," "Abraxis
BioScience," "Abraxis," "we," "us" and "our" refer to Abraxis BioScience, Inc.
(formerly New Abraxis, Inc.) and its subsidiaries, including our operating
subsidiary Abraxis BioScience, LLC; references to "Old Abraxis" refer to Abraxis
BioScience, Inc. (formerly American Pharmaceuticals, Inc.) prior to the 2007
separation; references to "APP" refer to APP Pharmaceuticals, Inc. and its
subsidiaries, including its operating subsidiary APP Pharmaceuticals Partners,
LLC (which we sometimes refer to as APP LLC); and references to the
"distribution," "separation," "2007 separation" or "spin-off" refer to the
transactions in which we separated from Old Abraxis and became an independent
publicly-traded company in November 2007. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| 06/2010 | -1.88 | NA | N/E | | 03/2010 | -2.07 | NA | N/E | | 12/2009 | -2.57 | NA | N/E | | 09/2009 | -6.64 | NA | N/E | | 06/2009 | -6.07 | NA | N/E | | 03/2009 | -7.59 | NA | N/E | | 12/2008 | -6.91 | NA | N/E | | 09/2008 | -2.50 | NA | N/E |
Key Financial Ratios and Statistics |
FYE:
12/31 |
| Profitability |
2009 |
Leverage |
2009 |
| Net Inc/Comm Equity | -0.08 | Total Liab/Total Assets | 0.21 | | Net Inc/Total Assets | -0.10 | Total Liab/Inv Cap | 0.25 | | Net Inc/Inv Cap | -0.12 | Total Liab/Comm Equity | 0.19 | | Pretax Inc/Net Sales | -0.30 | Interest Coverage Ratio | NA | | Net Inc/Net Sales | -0.29 | Curr Debt/Equity | NA | | Cash Flow/Net Sales | 0.01 | LTD/Equity | NA | | SG&A/NetSales | 0.56 | Total Debt/Equity | NA |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | 4.05 | Quick Ratio | 1.78 | | Inventory Turnover | 1.08 | Current Ratio | 2.08 | | Inventory Day Sales | 0.00 | Net Rec/Curr Assets | 0.20 | | Net Sales/Work Cap | 1.86 | Inv/Curr Assets | 0.15 | | Net Sales/PP&E | 1.52 | | |
Income Statement (Millions) |
| |
6/30/2010
|
3/31/2010
|
6/30/2009
|
3/31/2009
|
|
Total Revenues(Net Sales)
|
135.30
|
110.83
|
85.13
|
72.58
|
|
Cost of Goods Sold
|
50.11
|
22.63
|
14.62
|
9.13
|
|
Selling & Admin Exps
|
59.86
|
50.41
|
47.55
|
45.15
|
|
Operating Income
|
-20.75
|
-5.75
|
-26.40
|
-23.98
|
|
Interest Exp
|
NA
|
NA
|
NA
|
NA
|
|
Pretax Income
|
-19.92
|
-3.50
|
-24.39
|
-23.24
|
|
Other Income
|
1.67
|
3.25
|
1.68
|
-0.29
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
-15.86
|
-3.00
|
-23.43
|
-22.92
|
|
Assets
|
6/30/2010
|
3/31/2010
|
6/30/2009
|
3/31/2009
|
|
Cash & Short Term Investments
|
171.72
|
191.44
|
258.25
|
302.80
|
|
Receivables - Total
|
81.68
|
83.17
|
110.77
|
105.72
|
|
Inventories - Total
|
60.83
|
56.22
|
53.67
|
59.31
|
|
Total Current Assets
|
338.44
|
362.18
|
443.57
|
495.82
|
|
Net Property, Plant & Equipment
|
262.16
|
247.42
|
227.19
|
181.37
|
|
Total Assets
|
1,060.12
|
1,081.09
|
1,125.35
|
1,131.00
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
160.46
|
176.07
|
140.97
|
133.07
|
|
Debt in Current Liabilities
|
0.00
|
NA
|
0.00
|
0.00
|
|
Total Current Liabilities
|
163.34
|
179.23
|
144.16
|
136.67
|
|
Long-Term Debt
|
NA
|
NA
|
NA
|
NA
|
|
Total Liabilities
|
217.72
|
239.68
|
235.82
|
221.79
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
9.20
|
9.62
|
3.93
|
-0.38
|
|
Preferred Stock
|
NA
|
NA
|
NA
|
NA
|
|
Common Stock
|
0.04
|
0.04
|
0.04
|
0.04
|
|
Retained Earnings
|
-394.67
|
-378.81
|
-319.04
|
-295.61
|
|
Treasury Stock
|
NA
|
NA
|
-0.87
|
NA
|
|
Total Stockholders' Equity
|
842.40
|
841.41
|
889.54
|
909.21
|
|
Total Liabilities and Stockholders' Equity
|
1,060.12
|
1,081.09
|
1,125.35
|
1,131.00
|
Cash Flow Summary (Millions) |
|
Categories
|
6/30/2010
|
3/31/2010
|
6/30/2009
|
3/31/2009
|
|
Net Cash Provided by Operating Activities
|
-2.49
|
5.72
|
5.65
|
9.37
|
|
Net Cash Provided by Investing Activities
|
-27.12
|
-18.99
|
-49.42
|
-13.24
|
|
Net Cash Provided by Financing Activities
|
10.00
|
1.40
|
-0.86
|
0.27
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 12/2007 | 333.69 | -41.60 | -1.04 | | 12/2008 | 345.31 | -276.77 | -6.91 | | 12/2009 | 359.05 | -103.12 | -2.57 | | Growth Rates | 3.73 | -- | -- |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| Institutional | 06/30/10 | 97 | 6,495 | 16.05 |
|
Report Date :
8/30/2010
 Copyright
2010, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|